$LLY next $1T company?
🚀 Eli Lilly’s weight-loss drug tirzepatide has taken the world by storm! After its success, CEO Dave Ricks is accelerating the development of even more powerful obesity treatments. Stay tuned for more breakthroughs! 🌟
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.